Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Insulin resistance and nonalcoholic steatohepatitis (NASH), characterized by hepatic steatosis combined with inflammation, are major sequelae of obesity. Currently, lifestyle modification (i.e., weight loss) is the first‐line therapy for NASH. However, weight loss resolves steatosis but not inflammation. In this study, we tested the ability of resolvin D1 (RvD1), an anti‐inflammatory and proresolving molecule, to promote the resolution initiated by calorie restriction in obese mice with NASH. Calorie restriction reduced adipose and liver weight (–56 and –13%, respectively; P< 0.001), serum leptin and resistin levels, hepatic steatosis, and insulin resistance. In addition to these, mice receiving RvD1 during the dietary intervention showed increased adiponectin expression at both the mRNA and protein levels and reduced liver macrophage infiltration (–15%, P<0.01). Moreover, RvD1 skewed macrophages from an M1‐ to an M2‐like anti‐inflammatory phenotype, induced a specific hepatic miRNA signature (i.e., miR‐219‐5p and miR‐199a‐5p), and reduced inflammatory adipokine mRNA and protein expression and macrophage innate immune response. In precision‐cut liver slices (PCLSs), which override the influence of circulating factors, RvD1 attenuated hypoxia‐induced mRNA and protein expression of COX‐2, IL‐1β, IL‐6, and CCR7. Of note, RvD1 anti‐inflammatory actions were absent in macrophage‐depleted PCLSs. In summary, RvD1 acts as a facilitator of the hepatic resolution process by reducing the inflammatory component of obesity‐induced NASH.—Rius, B., Titos, E., Morán‐Salvador, E., López‐Vicario, C., García‐Alonso, V., González‐Périz, A., Arroyo, V., Claria, J. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis. FASEB J. 28, 836–848 (2014). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 2×
“On the other hand, the direct effects of RvD1 on leukocytes are well established (28).”
BackgroundWeight loss and lipolysis promote a dynamic immune response in murine adipose tissue
Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., & Ferrante, A. W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42845 · Cited by 726 · cited 3×
“Although there is limited information on this question, the mechanisms responsible for this transient accumulation appear to be related to the bulk release of fatty acids during the process of weight loss (21).”
BackgroundInfluentialOmega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569
Novel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421 · cited 3×
“In this regard, resolvins have been shown to regulate adhesion molecules on leukocytes that down-regulate cell–cell interactions, including adhesion and migration of inflammatory cells into sites of active inflammation (7, 26, 27).”
BackgroundTitos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., & Clària, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100225 · Cited by 412
Self-citationMicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuits
Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., & Serhan, C. N. (2011) · The FASEB Journal · doi:10.1096/fj.10-169599 · Cited by 292 · cited 16×
“These changes were confirmed by measuring the protein expression of COX-2 and IL-1 in the PCLSs by Western blot analysis (Fig.”
BackgroundInfluential
Cited by
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Serhan, C. N. (2017) · The FASEB Journal · doi:10.1096/fj.201601222r · Cited by 555
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Parthasarathy, G., Revelo, X., & Malhi, H. (2020) · Hepatology Communications · doi:10.1002/hep4.1479 · Cited by 414
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Musso, G., Cassader, M., & Gambino, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.3 · Cited by 412
Metadata
- Authors
- Rius, B., Titos, E., Morán‐Salvador, E., López‐Vicario, C., García‐Alonso, V., González‐Périz, A., Arroyo, V., & Claria, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-11-18
- Volume
- 28
- Issue
- 2
- Pages
- 836-848
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2035922639
- Cited by
- 107
- References
- 12
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis. https://app.cochat.ai/papers/10.1096/fj.13-235614
- The paper
- Rius, B., Titos, E., Morán‐Salvador, E., López‐Vicario, C., García‐Alonso, V., González‐Périz, A., Arroyo, V., & Claria, J. (2014). Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis. The FASEB Journal. https://doi.org/10.1096/fj.13-235614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.